EdgarLookup

ARES CAPITAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that ARES CAPITAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
4.2%
Return on Assets
Net income ÷ assets
1.18x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.30B Feb 4, 2026
FY2025 Dec 31, 2024 $1.52B Feb 4, 2026
FY2025 Dec 31, 2023 $1.52B Feb 4, 2026
FY2024 Dec 31, 2022 $600.00M Feb 5, 2025
FY2023 Dec 31, 2021 $1.57B Feb 7, 2024
FY2022 Dec 31, 2020 $484.00M Feb 7, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.72B) Feb 4, 2026
FY2025 Dec 31, 2024 ($2.13B) Feb 4, 2026
FY2025 Dec 31, 2023 $511.00M Feb 4, 2026
FY2024 Dec 31, 2022 ($1.36B) Feb 5, 2025
FY2023 Dec 31, 2021 ($2.46B) Feb 7, 2024
FY2022 Dec 31, 2020 ($580.00M) Feb 7, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $31.24B Feb 4, 2026
FY2025 Dec 31, 2024 $28.25B Feb 4, 2026
FY2024 Dec 31, 2023 $23.80B Feb 5, 2025
FY2023 Dec 31, 2022 $22.40B Feb 7, 2024
FY2022 Dec 31, 2021 $20.84B Feb 7, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.92B Feb 4, 2026
FY2025 Dec 31, 2024 $14.90B Feb 4, 2026
FY2024 Dec 31, 2023 $12.60B Feb 5, 2025
FY2023 Dec 31, 2022 $12.84B Feb 7, 2024
FY2022 Dec 31, 2021 $11.98B Feb 7, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.32B Feb 4, 2026
FY2025 Dec 31, 2024 $13.36B Feb 4, 2026
FY2025 Dec 31, 2023 $11.20B Feb 4, 2026
FY2025 Dec 31, 2022 $9.56B Feb 4, 2026
FY2025 Dec 31, 2021 $8.87B Feb 4, 2026
FY2025 Dec 31, 2020 $7.18B Feb 4, 2026
FY2025 Dec 31, 2019 $7.47B Feb 4, 2026
FY2025 Dec 31, 2018 $7.30B Feb 4, 2026
FY2025 Dec 31, 2017 $7.10B Feb 4, 2026
FY2025 Dec 31, 2016 $5.17B Feb 4, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $958.00M Feb 4, 2026
FY2025 Dec 31, 2024 $852.00M Feb 4, 2026
FY2024 Dec 31, 2023 $462.00M Feb 5, 2025
FY2023 Dec 31, 2022 ($2.00M) Feb 7, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $638.00M Feb 4, 2026
FY2025 Dec 31, 2024 $635.00M Feb 4, 2026
FY2024 Dec 31, 2023 $535.00M Feb 5, 2025
FY2023 Dec 31, 2022 $303.00M Feb 7, 2024
FY2022 Dec 31, 2021 $372.00M Feb 7, 2023

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.99B Feb 4, 2026
FY2025 Dec 31, 2024 $13.73B Feb 4, 2026
FY2024 Dec 31, 2023 $11.88B Feb 5, 2025
FY2023 Dec 31, 2022 $12.21B Feb 7, 2024
FY2022 Dec 31, 2021 $11.02B Feb 7, 2023

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 4, 2026
FY2025 Dec 31, 2024 2 Feb 4, 2026
FY2025 Dec 31, 2023 2 Feb 4, 2026
FY2024 Dec 31, 2022 1 Feb 5, 2025
FY2023 Dec 31, 2021 3 Feb 7, 2024
FY2022 Dec 31, 2020 1 Feb 7, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 4, 2026
FY2025 Dec 31, 2024 2 Feb 4, 2026
FY2025 Dec 31, 2023 2 Feb 4, 2026
FY2024 Dec 31, 2022 1 Feb 5, 2025
FY2023 Dec 31, 2021 3 Feb 7, 2024
FY2022 Dec 31, 2020 1 Feb 7, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 718.00M Feb 4, 2026
FY2025 Dec 31, 2024 672.00M Feb 4, 2026
FY2025 Dec 31, 2023 582.00M Feb 4, 2026
FY2025 Dec 31, 2022 519.00M Feb 4, 2026
FY2025 Dec 31, 2021 468.00M Feb 4, 2026
FY2025 Dec 31, 2020 423.00M Feb 4, 2026
FY2025 Dec 31, 2019 431.00M Feb 4, 2026
FY2025 Dec 31, 2018 426.00M Feb 4, 2026
FY2025 Dec 31, 2017 426.00M Feb 4, 2026
FY2025 Dec 31, 2016 314.00M Feb 4, 2026